tirzepatide compound lawsuit update FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now Drugmakers battle pharmacies over compounded

Special populations A few groups should approach the first dose with extra awareness

"Our nomination provides numerous examples of these risks, including unknown impurities, peptide-related impurities, incorrect strengths, and even instances where no semaglutide was present in the product at all," Novo Nordisk spokesperson Jamie Bennet wrote in an email to NPR

Overdosing means unnecessary side effects, from nausea to vomiting to diarrhea, that could set your progress back weeks

In the mid-90s, there was renewed interest in phentermine in combination with another anorectic, fenfluramine, for the treatment of obesity and substance abuse, however, little scientific data support this practice

Great Fast shipping & such an easy convenience